Biotechnology News

October 25, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information suggests that managed market groups benefit from carefully constructing narratives for every payer presentation.

October 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron's ACE-536 demonstrates ability to treat both the severe anemia and serious organ damage due to iron overload in a preclinical model of rare blood disorder, beta-thalassemia

October 25, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces reporting date and time for Q3 2012 financial results.

October 25, 2012

SAN ANTONIO, Texas--(BUSINESS WIRE)--GenSpera and the Clinical Trial Network of Texas initiate Phase II G-202 trial in liver cancer.

October 25, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the third quarter of 2012 as follows: Quarterly Highlights: Achieved quarterly...

October 25, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics Army-funded Oxycyte preclincal studies to establish the product's safety profile is well underway and results are starting to come in.

October 25, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics has completed target enrollment of its second Phase 3 clinical trial of dalbavancin, under investigation for the treatment of ABSSSI caused by susceptible gram-positive bacteria.

October 25, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) reported total revenue of $1,419 million for the third quarter of 2012, a 14 percent increase from the same period in 2011. Adjusted (Non-GAAP) net income for the third quarter of...

October 25, 2012

SAN DIEGO--(BUSINESS WIRE)--Cytori announces that two investigator sponsored studies using their cell therapy have been approved at Kanazawa University in Japan. The trials are for ischemic heart failure & cirrhosis of the liver

October 25, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to provide a corporate update and discuss the Company's third quarter 2012 financial results on Thursday, November 8, at 9:...

October 25, 2012

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) today announced third quarter 2012 financial results, delivering revenue growth of 6 percent to $1.4 billion and non-GAAP diluted Earnings Per Share (EPS) growth of 19 percent. Third...

October 25, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Elixir Medical Announces Enrollment Completion of DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold. Successful Live Case follow-up at TCT 2012. 1 yr MSCT Follow-up for DESolve FIM.

October 25, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and...

October 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus Licensee Sanofi to Continue Prednisporin Development Under a Third-Party Sublicense

October 25, 2012

LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories Inc. (Nasdaq: CBRX) (the “Company”) received a letter on October 24, 2012, from the Nasdaq Stock Market indicating that the Company no longer meets the minimum bid price requirement for...

October 25, 2012

--(BUSINESS WIRE)--Sanovas, Inc.:   WHO: Dr. Stephen C. Schimpff, physician, educator, scientist, hospital CEO, cancer researcher and author   Students, researchers, consumers, medical professionals, health care executives, patients and others...

October 25, 2012

MONTREAL--(BUSINESS WIRE)--Thrasos Therapeutics(TM) announced that it has completed a $35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI).

October 25, 2012

PARIS--(BUSINESS WIRE)--Each year the American Association for the Advancement of Science, which publishes the prestigious journals Science and Science Translational Medicine, the Karolinska institute in Stockholm, the DMMGF foundation and the...

October 25, 2012

BASEL, Switzerland--(BUSINESS WIRE)--Regulatory News:  Novartis (SIX: NOVN) (NYSE:NVS): Key figures         Q3 2012       Q3 2011       % change       9M 2012       9M 2011       % change         USD m       USD m       USD       cc       USD m...

October 24, 2012

TORRANCE, Calif.--(BUSINESS WIRE)--On Nov 16-17, Phenomenex will hand pack 150,000 meals to feed starving children in the developing world through a partnership with Feed My Starving Children. All are invited to join and volunteer.

October 24, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the Credit Suisse 21st Annual Healthcare Conference on Wednesday, November 14, at 9:30 a.m. (CT). The live webcast of Baxter’s...

October 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on October 24, 2012. This dividend is payable on February 8, 2013, to all...

October 24, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today financial results for the third quarter and nine months ended September 30, 2012. Revenues for the third quarter were $0.4 million, compared to $0.4 million for...

October 24, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced financial results for the third quarter ended September 30, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and...

October 24, 2012

MONTREAL--(BUSINESS WIRE)--Clinical studies have shown that an investigational new drug, pomalidomide, has demonstrated overall survival in a clinical trial of myeloma patients who had undergone multiple prior treatments.

October 24, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Nearly half of surveyed companies report coordinating through globally centralized market research groups.

October 24, 2012

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology closed its previously announced $138 million public offering of common stock.

October 24, 2012

NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)--The IMF says pomalidomide, an investigational drug for multiple myeloma, has demonstrated overall survival even in patients who have undergone multiple previous treatments, as shown in Phase III study

October 24, 2012

DALLAS--(BUSINESS WIRE)--Statewide Clinical Trials Network of TX (CTNeT) Announces Liver Cancer Study Will Launch Organization’s Portfolio of Clinical Trials; study evaluating activity of GenSpera's lead drug candidate G-202

October 24, 2012

NEW YORK--(BUSINESS WIRE)--Andrew B. Roth, a Member of the Health Law Practice of Mintz Levin, will present during an American Health Lawyers Association (AHLA) Graduate Medical Education Bootcamp Webinar on October 25.

October 24, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today that the European Commission has given conditional marketing authorization for XALKORI® (crizotinib) in the European Union (EU) for the treatment of adults with previously treated anaplastic...

October 24, 2012

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Research presented at the AHA Scientific Sessions 2012 in Los Angeles will highlight the critical role the Atherotech VAP Lipid Panel plays in clinical research and heart disease risk assessment.

October 24, 2012

LOS ANGELES--(BUSINESS WIRE)--Thermo Fisher Scientific sells Laboratory Workstations division to middle market acquisition and operations firm, OpenGate Capital

October 24, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Acusphere, Inc. (ACUSD.PK) today announced that it has submitted the Marketing Authorisation Application (MAA) for its lead product candidate, Imagify™ (Perflubutane Polymer Microspheres) lyophilisate for...

October 24, 2012

LIBERTYVILLE, Ill.--(BUSINESS WIRE)--Valent BioSciences Corporation (VBC) announced it has hired Mike Daily as plant manager for its new state-of-the art biorational production facility in Osage, IA. The $150 million plant is slated to begin...

October 24, 2012

ST. LOUIS--(BUSINESS WIRE)--Mediomics, LLC has been awarded a $997,251 Phase II SBIR contract (HHSN261201200081C) from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services.

October 24, 2012

BERKELEY, Calif.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials sciences, and AxioMed Spine Corporation, an innovator in the field of spinal implant devices, today announced that they have revised and extended an existing...

October 24, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics Inc. (Mirna), development and commercialization of microRNA completion of a $34.5 million Series C financing

October 24, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Sequenta, Inc. today announced it has received Clinical Laboratory Improvement Amendments (CLIA) certification.

October 24, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that it will report its third quarter and year-to-date 2012 financial results on Wednesday, November 7, 2012, after the close of financial markets. Following...

October 24, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information’s new study finds that one-quarter of Top 20 drug companies have centralized compliance teams.

October 24, 2012

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, announced today the closing of its previously announced underwritten public offering of 9,200,000...

October 24, 2012

MALVERN, Pa.--(BUSINESS WIRE)--Aclaris Therapeutics Inc., a privately held specialty pharmaceutical company dedicated to developing dermatological therapeutics, announced today that it has secured $21 million in Series A financing.

October 24, 2012

NEW YORK--(BUSINESS WIRE)--CIT Group Inc. (NYSE: CIT), a leading provider of financing to small businesses and middle market companies, today announced that it arranged and syndicated a $75 million senior secured credit facility to Dallas-based...

October 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND Biosciences to Present at Lazard Capital Markets Healthcare Conference

October 24, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Alvine Pharmaceuticals Presents Celiac Disease Symptom Study Results at ACG Meeting

October 24, 2012

DALLAS--(BUSINESS WIRE)--Pomalidomide, being tested for multiple myeloma, improves overall survival in patients in a clinical trial. Leaders of Tackle Cancer Foundation say there’s hopeful news for patients with myeloma.

October 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--GnuBIO unveils the prototype of the first ever benchtop fully integrated DNA sequencing system. This system will be a paradigm shift in healthcare.

October 24, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-producing...